🧬Insights about the company winning against cancer 📈The potential to save millions & make millions 🤝Unaffiliated with Alpha Tau Medical
Joined March 2025
- Tweets826
- Following114
- Followers615
- Likes1.7K
Alpha Tau (NASDAQ: $DRTS) Announces Inclusion in the Flagship TA-90 and TA-125 Indices of the Tel Aviv Stock Exchange
Funds that track these TASE benchmark indexes are expected to add Alpha Tau shares to their holdings, Effective November 5, 2026
“Above all I want to mention our patients and their families, they are the real reason we get up in the morning. The true success of $DRTS won’t be measured solely by the market cap or share price, it will be measured first and foremost by the amount of people we help, the life we manage to extend and the hope we bring the families”
Alpha Tau CEO Uzi Sofer with a message at the TASE opening ceremony honoring his company
“The company is expected to join the TASE indexes (TA-90 and TA-125) in the upcoming indexes update (November 5, 2026)”
The Head of Sales and Market Development at the Tel Aviv Stock Exchange (TASE) officially welcomes $DRTS at the opening ceremony
Alpha Tau (NASDAQ: $DRTS) “rings the bell” to start the TASE (Tel Aviv Stock Exchange) trading day
CEO Uzi Sofer: “This is just the beginning”
The company has been confirmed to join the indexes next Thursday (Nov 5)
Alpha Tau (NASDAQ: $DRTS) “rings the bell” to start the TASE (Tel Aviv Stock Exchange) trading day
CEO Uzi Sofer: “This is just the beginning”
The company has been confirmed to join the indexes next Thursday (Nov 5)
Alpha Tau (NASDAQ: $DRTS) and Samsung Medical Center Sign MOU to Explore Clinical Trial of Alpha DaRT® for Pancreatic Cancer Patients in Korea
$DRTS CEO at the Investment Generation Conference:
• We are preparing for MASS PRODUCTION
• The supply chain isn’t an issue, it’s actually part of our MOAT
• More countries coming soon
Alpha Tau is ready to commercialize worldwide and become an industry leader
Alpha Tau (NASDAQ: $DRTS) Announces FDA Approval to Expand Alpha DaRT® U.S. Recurrent Glioblastoma REGAIN Trial; New Trial Data to be Presented at SNO 2026 Annual Meeting
globenewswire.com/news-relea…
Congrats Dr. @joshuapalmermd! Can’t wait to hear your presentation at the Society for Neuro-Oncology (SNO) 2026 Annual Meeting.
Alpha Tau Insight retweeted
Alpha DaRT in focus at Guy Natan's Investment Generation conference.
CEO Uzi Sofer shared what it truly takes to bring a new cancer treatment modality from idea to patient—building the global capabilities to deliver individualized care.
Alpha Tau Insight retweeted
$DRTS CEO Uzi Sofer getting interviewed on Channel 10, The Israeli Financial Channel, amid the upcoming addition of the stock into the TA-90 and TA-125 indexes
Welcome to Guy Natan's Investment Generation Conference where $DRTS will be featured and presenting
Follow this thread and @AlphaTauInsight for on site reporting🧵⬇️
$DRTS CEO Uzi Sofer presenting on the main stage at Guy Natan's Investment Generation Conference
$DRTS CEO Uzi Sofer getting interviewed on Channel 10, The Israeli Financial Channel, amid the upcoming addition of the stock into the TA-90 and TA-125 indexes
Alpha Tau Insight retweeted
$DRTS CEO Uzi Sofer presenting on the main stage at Guy Natan's Investment Generation Conference
Alpha Tau Insight will be reporting on site.
Follow for updates.
$DRTS
Bringing new cancer therapy to patients takes more than tech—it needs evidence and global infrastructure.
Tomorrow, @AlphaTauMedical CEO Uzi Sofer speaks at the Investment Generation conference.
🗓 Oct 15 | 12:30 PM 📍 Cinema City, Rishon LeZion
Alpha Tau (NASDAQ: $DRTS & TASE: דרטס) is expected to join the TA-90 and TA-125 indexes this coming November, per reports
The company that has been dual listed and is trading on the TASE since August 13 is quickly making a name for itself in the growing local market
Source:
globes.co.il/news/article.as…
